Professor Alex Mirnezami

University of Southampton

Alex Mirnezami is Professor of Surgical Oncology in the University of Southampton and an Honorary Consultant Colorectal Surgeon. He has linked clinical and translational laboratory research interests, in the area of colorectal cancer and its progression and recurrence. His clinical area of interest is in locally advanced and locally recurrent colorectal cancers. His research interests are in microRNAs and their role in colorectal cancer progression, in particular stromal derived miRNAs, where he leads a lab with expertise in in vitro through to in vivo studies. He is also the CI on a number of clinical studies and local PI to others at his institution.

dont miss

Biomarkers of Epithelial to Mesenchymal Transition and their clinical relevance in colorectal cancer

An important event in the metastatic cascade is epithelial to mesenchymal transition (EMT), a reversible phenotypic switch, which endows malignant epithelial cells with the capacity to break free from one another and invade the surrounding stroma.
Our understanding of EMT has been significantly improved by the characterization of miRNAs and the mission critical transcription factors that influence the signalling pathways and downstream events that define EMT on a molecular level.
This seminar describes the latest findings in this field and presents the latest results from our group highlighting the key prognostic and predictive potential of biomarkers of EMT.

EVEN MORE SEMINARS

  • Nirmesh Patel: Speaking at the Oncology Convention

    Nirmesh Patel
    Cambridge Cancer Genomics

    Monitoring cancer evolution through smart genomics and liquid biopsies

  • Prof Samuel Janes: Speaking at the Oncology Convention

    Prof Samuel Janes
    University College London Hospitals

    Coming soon

  • Camilo Colaco: Speaking at the Oncology Convention

    Camilo Colaco
    ImmunoBiology

    The immunobiology of immunotherapy

  • Dr Christy Goldsmith: Speaking at the Oncology Convention

    Dr Christy Goldsmith
    Action Radiotherapy

    Improving patient outcomes with Stereotactic Ablative Body Radiotherapy (SABR)

  • Mohamed Torky: Speaking at the Oncology Convention

    Mohamed Torky
    Hospital Germans Trias i pujol. Barcelona. Spain

    Role of Radial-EBUS in diagnosis of lung cancer.